Abstract
Ectopic lipid deposition in muscle and liver is associated with the pathogenesis of type II diabetes. Hagberg et al. (2012) report that targeting the vascular endothelial growth factor (VEGF)-B restores insulin sensitivity and glucose tolerance by inhibiting endothelial-to-tissue lipid transport, opening promising avenues for diabetes therapy.
Original language | English |
---|---|
Pages (from-to) | 553-555 |
Number of pages | 3 |
Journal | Cell metabolism |
Volume | 16 |
Issue number | 5 |
DOIs | |
State | Published - Nov 7 2012 |